FUSION WITH E2A ALTERS THE TRANSCRIPTIONAL PROPERTIES OF THE HOMEODOMAIN PROTEIN PBX1 IN T(119) LEUKEMIAS

被引:0
|
作者
LEBRUN, DP
CLEARY, ML
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The t(1;19) chromosomal translocation is observed in pre-B cell acute lymphoblastic leukemias and results in expression of chimeric E2A-PBX1 proteins that contain transcriptional activation domains from E2A and the homeodomain of PBX1. Since homeodomains mediate DNA-binding, a potential model for the action of E2A-PBX1 is that it disrupts the transcriptional regulation of genes normally controlled by PBX1 or its closely-related family members PBX2 or PBX3. Using a binding site selection assay, we identified a consensus nucleotide sequence ATCAATCA specifically bound by the PBX1 homeodomain and those of its closely-related family members PBX2 and PBX3. An endogenous protein with the properties of PBX3b specifically bound to this sequence in nuclear extracts of precursor B cells. Transfection of reporter genes containing PBX binding sites linked to a minimal promoter demonstrated transactivation by E2A-PBX1 fusion protein dependent upon presence of the homeodomain. In contrast, wild-type PBX proteins were incapable of activating transcription. The striking differences in transcriptional properties of fusion and wild-type PBX proteins,provides strong functional evidence for the importance of aberrant transcriptional regulation in the genesis of t(l;19)-bearing leukemias.
引用
收藏
页码:1641 / 1647
页数:7
相关论文
共 50 条
  • [1] FUSION WITH E2A CONVERTS THE PBX1 HOMEODOMAIN PROTEIN INTO A CONSTITUTIVE TRANSCRIPTIONAL ACTIVATOR IN HUMAN LEUKEMIAS CARRYING THE T(119) TRANSLOCATION
    LU, Q
    WRIGHT, DD
    KAMPS, MP
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) : 3938 - 3948
  • [2] TRANSFORMATION PROPERTIES OF THE E2A-PBX1 CHIMERIC ONCOPROTEIN - FUSION WITH E2A IS ESSENTIAL, BUT THE PBX1 HOMEODOMAIN IS DISPENSABLE
    MONICA, K
    LEBRUN, DP
    DEDERA, DA
    BROWN, R
    CLEARY, ML
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) : 8304 - 8314
  • [3] THE T(1-19)(Q23-P13) RESULTS IN CONSISTENT FUSION OF E2A AND PBX1 CODING SEQUENCES IN ACUTE LYMPHOBLASTIC LEUKEMIAS
    HUNGER, SP
    GALILI, N
    CARROLL, AJ
    CRIST, WM
    LINK, MP
    CLEARY, ML
    BLOOD, 1991, 77 (04) : 687 - 693
  • [4] Evidence for Hox and E2A–PBX1 collaboration in mouse T-cell leukemia
    J Bijl
    J Krosl
    C-E Lebert-Ghali
    J Vacher
    N Mayotte
    G Sauvageau
    Oncogene, 2008, 27 : 6356 - 6364
  • [5] Observance of PBX1/E2A gene fusion caused by the der(19) or t(1;19) in adult hematologic malignancies.
    Shearer, BM
    Flynn, HC
    Ketterling, RP
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 660 - 660
  • [6] CLINICAL FEATURES AND PROGNOSTIC SIGNIFICANCE OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIAWITH E2A/PBX1 FUSION GENE
    Pang, L.
    Che, L.
    Guo, D.
    He, H.
    Ji, Z.
    Shao, X.
    Chai, Y.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 187 - 187
  • [7] A case of mature B-cell ALL with coexistence of t(1;19) and t(14;18) and expression of the E2A/PBX1 fusion gene
    Rowe, D
    Devaraj, PE
    Irving, JAE
    Hogarth, L
    Hall, AG
    Turner, GE
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (01) : 133 - 135
  • [8] E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells
    R P Bourette
    M-F Grasset
    G Mouchiroud
    Oncogene, 2007, 26 : 234 - 247
  • [9] E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells
    Bourette, R. P.
    Grasset, M-F
    Mouchiroud, G.
    ONCOGENE, 2007, 26 (02) : 234 - 247
  • [10] Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: Characterization and diagnostic utility
    Sang, BC
    Shi, LR
    Dias, P
    Liu, L
    Wei, J
    Wang, ZX
    Monell, CR
    Behm, F
    Gruenwald, S
    BLOOD, 1997, 89 (08) : 2909 - 2914